logo
Breadcrumbs Image

Anti Malarial Drug Market

Anti Malarial Drug Market

2021-2027 Global and Regional Anti-Malarial Drug Industry Status and Prospects Professional Market Research Report Standard Version


Date: Aug-2021 | Id: MACRC-72530 | Geographical Scope: Global | Publisher: Mnemonics Research

The global Anti-Malarial Drug market was valued at 697.62 Million USD in 2020 and will grow with a CAGR of 2.56% from 2020 to 2027, based on Mnemonics Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Anti-malarial drugs (also called anti-malarials) are medications used for the treatment and prevention of malaria infection.
By Market Verdors:
GlaxoSmithKline
Ranbaxy
Zydus Cadila
Alvizia
Bayer
Ipca
Merck
F. Hoffmann-La Roche
Novartis
Pfizer

By Types:
Plasmodium Falciparum
Plasmodium Vivax
Plasmodium Malariae
Plasmodium Ovale

By Applications:
Hospital Pharmacy
Retail Pharmacy
E-Commerce

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global  market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

Get Started with Request an Overview
Get Started with Download Brochure
Get Started with Request Methodology
Get Started with Share Customization
Get Started with Submit RFP
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Anti-Malarial Drug Market Size Analysis from 2022 to 2027
1.5.1 Global Anti-Malarial Drug Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Anti-Malarial Drug Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Anti-Malarial Drug Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Anti-Malarial Drug Industry Impact
Chapter 2 Global Anti-Malarial Drug Competition by Types, Applications, and Top Regions and Countries
2.1 Global Anti-Malarial Drug (Volume and Value) by Type
2.1.1 Global Anti-Malarial Drug Consumption and Market Share by Type (2016-2021)
2.1.2 Global Anti-Malarial Drug Revenue and Market Share by Type (2016-2021)
2.2 Global Anti-Malarial Drug (Volume and Value) by Application
2.2.1 Global Anti-Malarial Drug Consumption and Market Share by Application (2016-2021)
2.2.2 Global Anti-Malarial Drug Revenue and Market Share by Application (2016-2021)
2.3 Global Anti-Malarial Drug (Volume and Value) by Regions
2.3.1 Global Anti-Malarial Drug Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Anti-Malarial Drug Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Anti-Malarial Drug Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Anti-Malarial Drug Consumption by Regions (2016-2021)
4.2 North America Anti-Malarial Drug Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Anti-Malarial Drug Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Anti-Malarial Drug Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Anti-Malarial Drug Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Anti-Malarial Drug Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Anti-Malarial Drug Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Anti-Malarial Drug Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Anti-Malarial Drug Sales, Consumption, Export, Import (2016-2021)
4.10 South America Anti-Malarial Drug Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Anti-Malarial Drug Market Analysis
5.1 North America Anti-Malarial Drug Consumption and Value Analysis
5.1.1 North America Anti-Malarial Drug Market Under COVID-19
5.2 North America Anti-Malarial Drug Consumption Volume by Types
5.3 North America Anti-Malarial Drug Consumption Structure by Application
5.4 North America Anti-Malarial Drug Consumption by Top Countries
5.4.1 United States Anti-Malarial Drug Consumption Volume from 2016 to 2021
5.4.2 Canada Anti-Malarial Drug Consumption Volume from 2016 to 2021
5.4.3 Mexico Anti-Malarial Drug Consumption Volume from 2016 to 2021
Chapter 6 East Asia Anti-Malarial Drug Market Analysis
6.1 East Asia Anti-Malarial Drug Consumption and Value Analysis
6.1.1 East Asia Anti-Malarial Drug Market Under COVID-19
6.2 East Asia Anti-Malarial Drug Consumption Volume by Types
6.3 East Asia Anti-Malarial Drug Consumption Structure by Application
6.4 East Asia Anti-Malarial Drug Consumption by Top Countries
6.4.1 China Anti-Malarial Drug Consumption Volume from 2016 to 2021
6.4.2 Japan Anti-Malarial Drug Consumption Volume from 2016 to 2021
6.4.3 South Korea Anti-Malarial Drug Consumption Volume from 2016 to 2021
Chapter 7 Europe Anti-Malarial Drug Market Analysis
7.1 Europe Anti-Malarial Drug Consumption and Value Analysis
7.1.1 Europe Anti-Malarial Drug Market Under COVID-19
7.2 Europe Anti-Malarial Drug Consumption Volume by Types
7.3 Europe Anti-Malarial Drug Consumption Structure by Application
7.4 Europe Anti-Malarial Drug Consumption by Top Countries
7.4.1 Germany Anti-Malarial Drug Consumption Volume from 2016 to 2021
7.4.2 UK Anti-Malarial Drug Consumption Volume from 2016 to 2021
7.4.3 France Anti-Malarial Drug Consumption Volume from 2016 to 2021
7.4.4 Italy Anti-Malarial Drug Consumption Volume from 2016 to 2021
7.4.5 Russia Anti-Malarial Drug Consumption Volume from 2016 to 2021
7.4.6 Spain Anti-Malarial Drug Consumption Volume from 2016 to 2021
7.4.7 Netherlands Anti-Malarial Drug Consumption Volume from 2016 to 2021
7.4.8 Switzerland Anti-Malarial Drug Consumption Volume from 2016 to 2021
7.4.9 Poland Anti-Malarial Drug Consumption Volume from 2016 to 2021
Chapter 8 South Asia Anti-Malarial Drug Market Analysis
8.1 South Asia Anti-Malarial Drug Consumption and Value Analysis
8.1.1 South Asia Anti-Malarial Drug Market Under COVID-19
8.2 South Asia Anti-Malarial Drug Consumption Volume by Types
8.3 South Asia Anti-Malarial Drug Consumption Structure by Application
8.4 South Asia Anti-Malarial Drug Consumption by Top Countries
8.4.1 India Anti-Malarial Drug Consumption Volume from 2016 to 2021
8.4.2 Pakistan Anti-Malarial Drug Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Anti-Malarial Drug Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Anti-Malarial Drug Market Analysis
9.1 Southeast Asia Anti-Malarial Drug Consumption and Value Analysis
9.1.1 Southeast Asia Anti-Malarial Drug Market Under COVID-19
9.2 Southeast Asia Anti-Malarial Drug Consumption Volume by Types
9.3 Southeast Asia Anti-Malarial Drug Consumption Structure by Application
9.4 Southeast Asia Anti-Malarial Drug Consumption by Top Countries
9.4.1 Indonesia Anti-Malarial Drug Consumption Volume from 2016 to 2021
9.4.2 Thailand Anti-Malarial Drug Consumption Volume from 2016 to 2021
9.4.3 Singapore Anti-Malarial Drug Consumption Volume from 2016 to 2021
9.4.4 Malaysia Anti-Malarial Drug Consumption Volume from 2016 to 2021
9.4.5 Philippines Anti-Malarial Drug Consumption Volume from 2016 to 2021
9.4.6 Vietnam Anti-Malarial Drug Consumption Volume from 2016 to 2021
9.4.7 Myanmar Anti-Malarial Drug Consumption Volume from 2016 to 2021
Chapter 10 Middle East Anti-Malarial Drug Market Analysis
10.1 Middle East Anti-Malarial Drug Consumption and Value Analysis
10.1.1 Middle East Anti-Malarial Drug Market Under COVID-19
10.2 Middle East Anti-Malarial Drug Consumption Volume by Types
10.3 Middle East Anti-Malarial Drug Consumption Structure by Application
10.4 Middle East Anti-Malarial Drug Consumption by Top Countries
10.4.1 Turkey Anti-Malarial Drug Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Anti-Malarial Drug Consumption Volume from 2016 to 2021
10.4.3 Iran Anti-Malarial Drug Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Anti-Malarial Drug Consumption Volume from 2016 to 2021
10.4.5 Israel Anti-Malarial Drug Consumption Volume from 2016 to 2021
10.4.6 Iraq Anti-Malarial Drug Consumption Volume from 2016 to 2021
10.4.7 Qatar Anti-Malarial Drug Consumption Volume from 2016 to 2021
10.4.8 Kuwait Anti-Malarial Drug Consumption Volume from 2016 to 2021
10.4.9 Oman Anti-Malarial Drug Consumption Volume from 2016 to 2021
Chapter 11 Africa Anti-Malarial Drug Market Analysis
11.1 Africa Anti-Malarial Drug Consumption and Value Analysis
11.1.1 Africa Anti-Malarial Drug Market Under COVID-19
11.2 Africa Anti-Malarial Drug Consumption Volume by Types
11.3 Africa Anti-Malarial Drug Consumption Structure by Application
11.4 Africa Anti-Malarial Drug Consumption by Top Countries
11.4.1 Nigeria Anti-Malarial Drug Consumption Volume from 2016 to 2021
11.4.2 South Africa Anti-Malarial Drug Consumption Volume from 2016 to 2021
11.4.3 Egypt Anti-Malarial Drug Consumption Volume from 2016 to 2021
11.4.4 Algeria Anti-Malarial Drug Consumption Volume from 2016 to 2021
11.4.5 Morocco Anti-Malarial Drug Consumption Volume from 2016 to 2021
Chapter 12 Oceania Anti-Malarial Drug Market Analysis
12.1 Oceania Anti-Malarial Drug Consumption and Value Analysis
12.2 Oceania Anti-Malarial Drug Consumption Volume by Types
12.3 Oceania Anti-Malarial Drug Consumption Structure by Application
12.4 Oceania Anti-Malarial Drug Consumption by Top Countries
12.4.1 Australia Anti-Malarial Drug Consumption Volume from 2016 to 2021
12.4.2 New Zealand Anti-Malarial Drug Consumption Volume from 2016 to 2021
Chapter 13 South America Anti-Malarial Drug Market Analysis
13.1 South America Anti-Malarial Drug Consumption and Value Analysis
13.1.1 South America Anti-Malarial Drug Market Under COVID-19
13.2 South America Anti-Malarial Drug Consumption Volume by Types
13.3 South America Anti-Malarial Drug Consumption Structure by Application
13.4 South America Anti-Malarial Drug Consumption Volume by Major Countries
13.4.1 Brazil Anti-Malarial Drug Consumption Volume from 2016 to 2021
13.4.2 Argentina Anti-Malarial Drug Consumption Volume from 2016 to 2021
13.4.3 Columbia Anti-Malarial Drug Consumption Volume from 2016 to 2021
13.4.4 Chile Anti-Malarial Drug Consumption Volume from 2016 to 2021
13.4.5 Venezuela Anti-Malarial Drug Consumption Volume from 2016 to 2021
13.4.6 Peru Anti-Malarial Drug Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Anti-Malarial Drug Consumption Volume from 2016 to 2021
13.4.8 Ecuador Anti-Malarial Drug Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Anti-Malarial Drug Business
14.1 GlaxoSmithKline
14.1.1 GlaxoSmithKline Company Profile
14.1.2 GlaxoSmithKline Anti-Malarial Drug Product Specification
14.1.3 GlaxoSmithKline Anti-Malarial Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Ranbaxy
14.2.1 Ranbaxy Company Profile
14.2.2 Ranbaxy Anti-Malarial Drug Product Specification
14.2.3 Ranbaxy Anti-Malarial Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Zydus Cadila
14.3.1 Zydus Cadila Company Profile
14.3.2 Zydus Cadila Anti-Malarial Drug Product Specification
14.3.3 Zydus Cadila Anti-Malarial Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Alvizia
14.4.1 Alvizia Company Profile
14.4.2 Alvizia Anti-Malarial Drug Product Specification
14.4.3 Alvizia Anti-Malarial Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Bayer
14.5.1 Bayer Company Profile
14.5.2 Bayer Anti-Malarial Drug Product Specification
14.5.3 Bayer Anti-Malarial Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Ipca
14.6.1 Ipca Company Profile
14.6.2 Ipca Anti-Malarial Drug Product Specification
14.6.3 Ipca Anti-Malarial Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Merck
14.7.1 Merck Company Profile
14.7.2 Merck Anti-Malarial Drug Product Specification
14.7.3 Merck Anti-Malarial Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 F. Hoffmann-La Roche
14.8.1 F. Hoffmann-La Roche Company Profile
14.8.2 F. Hoffmann-La Roche Anti-Malarial Drug Product Specification
14.8.3 F. Hoffmann-La Roche Anti-Malarial Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Novartis
14.9.1 Novartis Company Profile
14.9.2 Novartis Anti-Malarial Drug Product Specification
14.9.3 Novartis Anti-Malarial Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Pfizer
14.10.1 Pfizer Company Profile
14.10.2 Pfizer Anti-Malarial Drug Product Specification
14.10.3 Pfizer Anti-Malarial Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Anti-Malarial Drug Market Forecast (2022-2027)
15.1 Global Anti-Malarial Drug Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Anti-Malarial Drug Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Anti-Malarial Drug Value and Growth Rate Forecast (2022-2027)
15.2 Global Anti-Malarial Drug Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Anti-Malarial Drug Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Anti-Malarial Drug Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Anti-Malarial Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Anti-Malarial Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Anti-Malarial Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Anti-Malarial Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Anti-Malarial Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Anti-Malarial Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Anti-Malarial Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Anti-Malarial Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Anti-Malarial Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Anti-Malarial Drug Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Anti-Malarial Drug Consumption Forecast by Type (2022-2027)
15.3.2 Global Anti-Malarial Drug Revenue Forecast by Type (2022-2027)
15.3.3 Global Anti-Malarial Drug Price Forecast by Type (2022-2027)
15.4 Global Anti-Malarial Drug Consumption Volume Forecast by Application (2022-2027)
15.5 Anti-Malarial Drug Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology

Add to Cart

Single User

$ 3300.00

Site License

$ 5250.00

Enterprisewide

$ 7000.00